Innovent Biologics innoventbio.com


Public lists: BIO 2016 (619)

Innovent Biologics (信达生物制药) is a biopharmaceutical company in China focused on the development and manufacturing of complex, high-end biologics for both the Asian and global markets that meet EMEA and FDA/cGMP standards. Innovent's strategy is to advance its internal pipeline of proprietary biologic drugs and establish in/out-licensing agreements with global pharmaceutical/biotech companies. Because of its location and emphasis on quality, Innovent is able to leverage China's cost-ef...Show all

Innovent Biologics (信达生物制药) is a biopharmaceutical company in China focused on the development and manufacturing of complex, high-end biologics for both the Asian and global markets that meet EMEA and FDA/cGMP standards. Innovent's strate...Show all

Company (Alive / Active)

Phone: 0512-69566088

Fax:

168 Dongping Street
Suzhou Industrial Park
Suzhou, 215123
Jiangsu, China

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Innovent Biologics $535M Apr 26, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Innovent Biologics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 16 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Pd-1 antibodies Aug 09, 2016 Application
Recombinant fusion protein formulation Sep 25, 2015 Application
Protein inhibitors to complement and vegf pathways and methods of use thereof Nov 30, 2012 Application